Nyumbani › Limfadenopati ya Immunoblastic › Florida › Miami
Majaribio ya kliniki ya Limfadenopati ya Immunoblastic katika Miami, FL
Masomo 4 ya Limfadenopati ya Immunoblastic yanatafuta washiriki katika vituo vya Miami na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
InaajiriHatua 2
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
InaajiriHatua 3
- Sylvester Comprehensive Cancer Center University of Miami Miller School of Medicine, Miami
A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
InaajiriHatua 1
- Clinical Trial Site, Miami
A Registry for People With T-cell Lymphoma
InaajiriUtafiti wa uchunguzi
- University of Miami (Data Collection Only), Miami
Majaribio ya Limfadenopati ya Immunoblastic katika miji mingine
- New York City, NYUtafiti 5
- Chicago, ILUtafiti 4
- Houston, TXUtafiti 4
- Durham, NCUtafiti 4
- Baldwin Park, CAUtafiti 3
- Ann Arbor, MIUtafiti 3
- Columbus, OHUtafiti 3
- St. Louis, MOUtafiti 3
- Boston, MAUtafiti 3
- Atlanta, GAUtafiti 3
- New Haven, CTUtafiti 3
- Edison, NJUtafiti 3
Masomo mengine katika Miami
- Saratani ya MatitiUtafiti 42
- Saratani (aina zote)Utafiti 36
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 31
- Saratani ya ProstateUtafiti 27
- UnenepuUtafiti 27
- Leukemia ya Myeloid ya GhaflaUtafiti 24
- Saratani ya MetastasiUtafiti 24
- Kansari ya MayaiUtafiti 23
- Uzito Kupita KiasiUtafiti 23
- Multiple MyelomaUtafiti 21
- Colitis ya UlcerativeUtafiti 21
- Ugonjwa wa AlzheimerUtafiti 20
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.